Assessing survival time of outpatients with cervical cancer: at the university of Gondar referral hospital using the Bayesian approach

Abstract

Background Cervical cancer is the 4th most common cancer in women worldwide. as well as the 4th most common cause of cancer-related death. The main objective of this study was to identify factors that affect the survival time of outpatients with cervical cancer. Methods A retrolective study including outpatients with cervical cancer was carried out in a hospital. To achieve the aim, 322 outpatients with cervical cancer were included in the study based on the data taken from the medical records of patients enrolled from May 15, 2018, to May 15, 2022, at the University of Gondar referral hospital, Gondar, Ethiopia. The Kaplan–Meier plots and log-rank test were used for the comparison of survival functions; the Cox-PH model and Bayesian parametric survival models were used to analyze the survival times of outpatients with cervical cancer. Integrated nested Laplace approximation methods have been applied. Results Out of a total of 322 patients, 118 (36.6%) died as outpatients. The estimated median survival time for patients was 42 months. Using model selection criteria, the Bayesian log-normal accelerated failure time model was found to be appropriate. According to the results of this model, oral contraceptive use, HIV, stage, grade, co-morbid disease, history of abortion, weight, histology type, FIGO stage, radiation, chemotherapy, LVSI, metastatic number, regional nodes examined, and tumor size all have a significant impact on the survival time of outpatients with cervical cancer. The Bayesian log-normal accelerated failure time model accurately predicted the survival time of cervical cancer outpatients. Conclusions The findings of this study suggested that reductions in weight, treatment, the presence of comorbid disease, the presence of HIV, squamous cell histology type, having a history of abortion, oral contraceptive use, a large tumor size, an increase in the International Federation of Gynecologists and Obstetricians stage, an increase in metastasis number, an increase in grade, positive regional nodes, lymphatic vascular space invasion, and late stages of cancer all shortened the survival time of cervical cancer outpatients.

Assessing the survival time of women with breast cancer in Northwestern Ethiopia: using the Bayesian approach

“…Furthermore, logistic regression does not account for censoring observation, i.e., it does not hold for time-to-event data, therefore, these statistical methods are unable to account for the hospital patient survival rate. In addition to the Cox regression model, other parametric models have also been employed to examine the survival distribution of outpatients with breast cancer, including exponential, log-logistic, and Weibull log-normal models [ 17 ]. The parametric survival models might be more suitable to describe the survival data if it is possible to identify the distribution of the survival time [ 18 ].…”

An Accelerated Failure Time Model to Predict Cause-Specific Survival and Prognostic Factors of Lung and Bronchus Cancer Patients with at Least Bone or Brain Metastases: Development and Internal Validation Using a SEER-Based Study

“…The Cox proportional hazard (PH) model is frequently used. However, a more flexible option is to apply generalized parametric models [20][21][22][23][24]. A particular model called ZBLN is highly regarded as the preferred option due to its flexibility to real life data.…”

Analysis of the survival time of patients with heart failure with reduced ejection fraction: a Bayesian approach via a competing risk parametric model

“…This enables researchers to consider a broader and more diverse range of variables for examination, categorized by the cause of death. Therefore, Bayesian parametric models provide valuable tools for understanding the relationship between heart disease and survival outcomes [ 25 , 26 ].…”